Industry Insight
Our consultants contribute to industry
and professional conferences and publications. We do so in
a way that respects our obligations of confidentiality to
our clients.
White Papers and Presentations
Specialty Pharma Franchise Strategy
Presented at the CBI Specialty Pharma Conference
As a Session Presenter, PROFORMANT
Managing Partner Joseph Kozikowski, M.D., defined and analyzed comparable, publicly traded Therapeutic Franchise Model and Commercialization Model companies to help clarify the extent to which the Therapeutic Franchise business model can enable them to:
- Achieve Significant Amounts of Revenue
- Grow Revenue Faster
- Be Better-Rewarded for the Revenue Achieved
- Grow Profitably
- Be Better-Rewarded for the Earnings Achieved
- Outperform in a Sector Rally
- Create Significant Shareholder Value
2003 Pulmonary Biopharmaceuticals Outlook
Presented at the Academy of Managed Care Pharmacy
As a Session Presenter and Panelist, PROFORMANT
Managing Partner Joseph Kozikowski, M.D., analyzes and discusses:
- Importance of inhalation drug formulations
- Approaches to inhalation formulations
- Achieving superior performance
- Achieving regulatory approvals
- Current inhalation formulations
- Pipeline inhalation formulations
Biomedical Valuation: Contemporary Methods and Practice
Presented at the Massachusetts Institute
of Technology, Enterprise Financial Strategy Forum.
As Session Leader, Valuation, PROFORMANT
Managing Partner Joseph Kozikowski, M.D., explains and illustrates
contemporary approaches to:
- Free-Cash-Flow-to-Firm DCF valuations
- Selecting and calculating EER, WACC,
and EAR discount rates
- Black-Scholes option valuation methods
for technology, equity, and warrants
- Comparables valuation analysis for
development-stage firms
- Discounting private equity value for
illiquidity
- Using strategic alliance deal structure
to negotiate precise valuation at acquisition, while allowing
progress-enabling investment to be made at an early stage
when valuation is unclear
- Additional techniques and practical
considerations
Illustrative, anonymized actual case examples
drawn from the PROFORMANT case archives and a panel of senior
biomedical industry executives are presented and include the
valuation of:
- A bioengineered collagen matrix
- A protein-based growth factor complex
- A comarketed outpatient small molecule drug
- A protein-based preterm labor diagnostic
- An OTC otitis media medical device company
- A B-B online business process automation portal company
- Warrants in an online consumer health portal
|
